IP Library Granted Patent US 10,023,859
Granted Patent B2
US 10,023,859 · App. 15/382,807 · Granted Jul 17, 2018

Fabrication of hierarchical silica nanomembranes and uses thereof for solid phase extraction of nucleic acids

Inventors: Tza-Huei Wang (Timonium, MD); Yi Zhang (Baltimore, MD)
Assignee: The Johns Hopkins University
C12N15/1006B01D67/0069B01D67/0072B01D67/0083B01D71/027B01J20/103B01J20/261B01J20/28035B01J20/321B01J20/3225B01J20/3234B01J20/3297C12Q1/6806C23C14/10C23C14/221C23C16/44C25D1/006B01D69/06C23C18/1212C25D13/02C25D13/12
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,023,859
App. No.
15/382,807
Granted
Jul 17, 2018
Kind
B2
Abstract

The present invention provides a novel method to fabricate silica nanostructures on thin polymer films based on silica deposition and self-wrinkling induced by thermal shrinkage. These micro- and nano-scale structures have vastly enlarged the specific area of silica, thus the silica nanomembranes can be used for solid phase extraction of nucleic acids. The inventive silica nanomembranes are suitable for nucleic acid purification and isolation and demonstrated better performance than commercial particles in terms of DNA recovery yield and integrity. In addition, the silica nanomembranes have extremely high nucleic acid capacity due to its significantly enlarged specific surface area of silica. Methods of use and devices comprising the silica nanomembranes are also provided.

Claims (21)

1. A method for extracting nucleic acids from a sample comprising:

a) contacting the sample comprising nucleic acids with a sufficient amount of silica nanomembranes, wherein the silica nanomembranes comprise a heat shrunken polymer core coated with a silicon dioxide layer, and wherein the silicon dioxide layer comprises a surface structure comprising wrinkle structures having a length from about 10 nm to about 100 μm and/or discreet substantially planar flakes having a length from about 10 nm to about 100 μm; and

b) purifying said nucleic acids from the sample.

2. The method of claim 1 , wherein the sample is selected from the group consisting of: a cell, tissue, blood, serum body fluid, formalin-fixed paraffin embedded tissue, enzymatic reaction, plant, bacteria, and viral particle.

3. The method of claim 1 , further comprising at step a) deparaffinizing the sample.

4. The method of claim 3 , wherein washing comprises two or more washes.

5. The method of claim 3 , further comprising a drying step after washing.

6. The method of claim 3 , wherein deparaffinization comprises contacting the sample with an organic solvent.

7. The method of claim 6 , wherein the organic solvent is selected from the group consisting of: xylene, mineral oil, hexadecane, toluene, 5-chloro-2-methyl-4-isothiazolin-3-one, 5-chloro-2-methyl-4-isothiazolin-3-one; a terpene or isoparaffinic hydrocarbon, and 2-butoxyethanol.

8. The method of claim 6 , wherein step a) further comprises removing the organic solvent, and washing the sample.

9. The method of claim 1 , further comprising step c) desorbing the nucleic acids from the silica nanomembranes to obtain the isolated and purified nucleic acids from the sample.

10. The method of claim 9 , wherein at step c) the desorption of the nucleic acids from the silica nanomembranes is by application of an elution solution.

11. The method of claim 1 , wherein purifying said nucleic acids comprises washing the silica nanomembranes to remove any non-desired components.

12. The method of claim 1 , further comprising contacting the sample with a lysis and/or digestion solution prior to step a).

13. The method of claim 1 , wherein at step a) the nucleic acids are contacted with a chaotropic agent.

14. The method of claim 1 , further comprising at step a) contacting the sample with the sufficient amount of silica nanomembranes in the presence of an aqueous alcoholic solution.

15. The method of claim 1 , further comprising adding to the sample a DNAse or an RNAse to allow removal of non-desired DNA or RNA components prior to step a).

16. The method of claim 1 , wherein the nucleic acids are DNA.

17. The method of claim 1 , wherein the nucleic acids are RNA.

18. The method of claim 1 , wherein the nucleic acids are selected from the group consisting of: plasmid, genomic, mitochondrial, vesicle, and cell free sources.

19. The method of claim 1 , wherein the nucleic acids bind to the silica nanomembranes.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 4, 2018
From: WANG, TZA-HUEI; ZHANG, YI
To: THE JOHNS HOPKINS UNIVERSITY
Reel/Frame 045435/0551 →
CONFIRMATORY LICENSE Recorded Dec 28, 2016
From: JOHNS HOPKINS UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 041199/0041 →
Continuity (3)
Division 14341957 · Jul 28, 2014
Provisional Application 61862319 · Aug 5, 2013
Related Publication 20170096660A1 · Apr 6, 2017